Immunity to live: an immunopathoscore using the consensus Immunoscore to best define the risk of recurrence and death in stage IV metastatic patients

The consensus Immunoscore is a routine assay quantifying the adaptive immune response within the tumor microenvironment. Its evaluation in the primary tumor of patients with stages I/II/III colorectal cancer (CRC) has prognostic value that has been confirmed in multiple studies. For metastatic patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldin, Pamela, Van den Eynde, Marc, Mlecnik, Bernhard, Galon, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Author’s View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561331/
https://www.ncbi.nlm.nih.gov/pubmed/33110705
http://dx.doi.org/10.1080/2162402X.2020.1826133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7561331/
https://www.ncbi.nlm.nih.gov/pubmed/33110705
http://dx.doi.org/10.1080/2162402X.2020.1826133

Ejemplares similares